In accordance with the Nosocomial Infection Control Measures issued in 2006 by the National Health and Family Planning Commission, the Infection Control Department was officially established in 2007. Currently, the department has 6 staff members with Prof. Hu Bijie as the director. Other members are Gao Xiaodong, Cui Yangwen, Sun Wei, Shen Yan and Zhu Chendi.
The department always takes the national lead and plays a vital role in improving medical quality, and ensuring the safety of patients and medical staff. Prof. Hu Bijie was in the first group who received training related to the National Nosocomial InfectionSurveillance Network. The department has been awarded the Excellent Institution of Monitoring Work several times. From 1999 on, Shanghai Municipal Nosocomial Infection Quality Control Center became an ancillary part ofour hospital. Under the leadership of Prof. He Xianli and Prof. Hu Bijie, the Center has been awarded the Excellent Quality Control Center for many years in a row and the municipal management of nosocomial infection control has made significant improvements. At the end of 2008, the department became an ancillaryinstitution of Nosocomial Infection Control Division of China Preventive Medicine Association, with Prof. Hu Bijie as its Chairman.
The department’s performance has been recognized by its peers domestically. During the outbreak of SARS in 2003, the department was awarded “National Anti-SARS Stellar Group”. In 2006, it was awarded “Champion Institution of Nosocomial Infection Control”. Experts in this field from Zhejiang, Gansu and other provinces have frequently come to the department to study and visit. The department has been organizing continuing education for 9 years in a row and the student number keeps rising every year, which reached 3,000 in 2013. The department also hires nosocomial control experts from WHO and Hong Kong as honorary professors to assit the academic work.
With the support from hospital leaders and all the colleagues, the department conducts regular nosocomial infection management including inspection, prevention and control. We focused our efforts on the comprehensive interventions and control of antibiotic administration in dealing with three tube-related infections in ICUs, surgical site infectionand multi-drug-resistant bacterial infections, and haveachieved good effects. For example, from 2008 on, the morbidity of nosocomial infection, especially that of ICU patients’ ventilator associated pneumonia, and catheter associated urinary tract infection, has been decreasing every year. Since 2011 , the bacteria drug resistance situation has been alleviated to some extent.